Arcus Biosciences, Inc.
Arcus Biosciences, Inc.（RCUS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · RCUS · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
38
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Arcus Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
RCUS 季度内部人买卖趋势
RCUS 内幕交易卖出 · RCUS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · RCUS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
RCUS 高管卖出股份 · RCUS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | Azoy Alexander CAO | Sale | 2,562 | $66K | Form 4 |
| Dec 16, 2025 | Ribas Antoni Director | Gift | 5,050 | — | Form 4 |
| May 11, 2026 | Goeltz II Robert C. CFO | Sale | 7,763 | $199K | Form 4 |
| Jan 23, 2026 | Markus Richard Chief Medical Officer | Award | 24,000 | — | Form 4 |
| Jan 23, 2026 | ROSEN TERRY J CEO · Director | Award | 79,000 | — | Form 4 |
| Jan 23, 2026 | Jaen Juan C. President | Award | 31,000 | — | Form 4 |
| Jan 23, 2026 | Tang Carolyn C. General Counsel | Award | 24,000 | — | Form 4 |
| Jan 23, 2026 | Goeltz II Robert C. CFO | Award | 24,000 | — | Form 4 |
| Jan 23, 2026 | Azoy Alexander CAO | Award | 21,050 | — | Form 4 |
| Jan 23, 2026 | Jarrett Jennifer COO | Award | 31,000 | — | Form 4 |
| Jan 8, 2026 | ROSEN TERRY J CEO · Director | Gift | 35,000 | — | Form 4 |
| Jan 5, 2026 | Jaen Juan C. President | Sale | 29,670 | $633K | Form 4 |
| Jan 5, 2026 | Jaen Juan C. President | Sale | 2,053 | $46K | Form 4 |
| Jan 5, 2026 | Jaen Juan C. President | Sale | 100 | $2K | Form 4 |
| Dec 31, 2025 | Goeltz II Robert C. CFO | Sale | 6,552 | $153K | Form 4 |
| Dec 30, 2025 | ROSEN TERRY J CEO · Director | Gift | 2,400 | — | Form 4 |
| Dec 16, 2025 | Tang Carolyn C. General Counsel | Sale | 7,658 | $168K | Form 4 |
| Dec 17, 2025 | Tang Carolyn C. General Counsel | Sale | 6,810 | $151K | Form 4 |
| Dec 16, 2025 | Markus Richard Chief Medical Officer | Sale | 5,052 | $111K | Form 4 |
| Dec 17, 2025 | Markus Richard Chief Medical Officer | Sale | 4,494 | $100K | Form 4 |
| Dec 16, 2025 | Azoy Alexander CAO | Sale | 2,376 | $52K | Form 4 |
| Dec 17, 2025 | Azoy Alexander CAO | Sale | 2,113 | $47K | Form 4 |
| Dec 18, 2025 | Azoy Alexander CAO | Sale | 4,343 | $97K | Form 4 |
| Dec 16, 2025 | Goeltz II Robert C. CFO | Sale | 6,702 | $147K | Form 4 |
| Dec 17, 2025 | Goeltz II Robert C. CFO | Sale | 5,960 | $132K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 RCUS 内幕交易
RCUS 内幕交易
Arcus Biosciences, Inc.（RCUS）内幕交易数据来源于公司内部人（包括Jaen Juan C. (President), Azoy Alexander (CAO), Jarrett Jennifer (COO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。RCUS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Arcus Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
RCUS 内幕交易 · 5个问题Arcus Biosciences, Inc.（RCUS）的内部人包括高管和董事，如Jaen Juan C. (President), Azoy Alexander (CAO), Jarrett Jennifer (COO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026